Showing results (351-360 of 391) with videos related to

Sort By:
Pageof 40
Gynecologic Oncology|July 30, 2019
Prospective pilot trial with combination of propranolol with chemotherapy in patients with epithelial ovarian cancer and evaluation on circulating immune cell gene expressionLois M Ramondetta, Wei Hu, Premal H Thaker, et al.
Cancer Medicine|November 25, 2016
Survival of patients with metastatic leiomyosarcoma: the MD Anderson Clinical Center for targeted therapy experienceZhijie Wang, Naiyi Shi, Aung Naing, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 15, 2022
Patient outcomes following interval and delayed cytoreductive surgery in advanced ovarian cancer: protocol for a multicenter, international, cohort study (Global Gynaecological Oncology Surgical Outcomes Collaborative)Faiza Gaba, Karen Ash, Oleg Blyuss, et al.
The New England Journal of Medicine|November 1, 2018
Minimally Invasive versus Abdominal Radical Hysterectomy for Cervical CancerPedro T Ramirez, Michael Frumovitz, Rene Pareja, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 20, 2022
A Cross-Sectional Study of the Prevalence of Anal Dysplasia among Women with High-Grade Cervical, Vaginal, and Vulvar Dysplasia or Cancer: The PANDA StudySamantha Batman, Craig A Messick, Andrea Milbourne, et al.
The Lancet. Oncology|June 6, 2020
Quality of life in patients with cervical cancer after open versus minimally invasive radical hysterectomy (LACC): a secondary outcome of a multicentre, randomised, open-label, phase 3, non-inferiority trialMichael Frumovitz, Andreas Obermair, Robert L Coleman, et al.
Cancers|March 25, 2022
Molecular Correlates of Venous Thromboembolism (VTE) in Ovarian CancerDeanna Glassman, Nicholas W Bateman, Sanghoon Lee, et al.
Gynecologic Oncology|July 15, 2014
A multicenter prospective trial evaluating the ability of preoperative computed tomography scan and serum CA-125 to predict suboptimal cytoreduction at primary debulking surgery for advanced ovarian, fallopian tube, and peritoneal cancerRudy S Suidan, Pedro T Ramirez, Debra M Sarasohn, et al.
Gynecologic Oncology|October 8, 2024
The prognosis of stage IA cervical cancer: Subgroup analysis of the SCCAN studyZheng Yuan Ng, Ranjit Manchanda, Aldo Lopez, et al.
Nature Medicine|January 19, 2024
The IDEAL framework for surgical robotics: development, comparative evaluation and long-term monitoringHani J Marcus, Pedro T Ramirez, Danyal Z Khan, et al.
Pageof 40